Dentsply Sirona Reports Third Quarter 2016 Results

Go back to Dentsply Sirona Reports Third Quarter 2016 Results

UBS Raises Price Target on Dentsply Int'l (XRAY) to $67; Reiterates Neutral

November 7, 2016 7:30 AM EST

UBS reiterated a Neutral rating on DENTSPLY International (NASDAQ: XRAY), and raised the price target to $67.00 (from $64.00), following the company's 3Q earnings report. The miss on the top-line relative to consensus was a result of a change in dealer buying patterns where the company received fewer orders than usual ahead of its annual October price increases. The bottom end of EPS... More

Dentsply Int'l (XRAY) Tops Q3 EPS by 3c; Boosts FY16 EPS Outlook

November 4, 2016 6:40 AM EDT

Dentsply Int'l (NASDAQ: XRAY) reported Q3 EPS of $0.66, $0.03 better than the analyst estimate of $0.63. Revenue for the quarter came in at $954.2 million versus the consensus estimate of $967.68 million.

GUIDANCE:

Dentsply Int'l sees FY2016 EPS of $2.75 - $2.80, versus the consensus of... More